Form D · Venture Capital Fund
Innovative Pharma LLC
Staten Island, NY · CIK 0002098514
Offering snapshot reported Dec 8, 2025 · SEC filing
- Reported sold
- $5.13M Indefinite offering
- Investors reported
- 33 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 26, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 8, 2025 | Initial | $5,130,750 | No comparison | 33 | SEC filing |
Offering details
- Securities
- Equity, Pooled investment fund, Other
- Exemptions
- 3C.1, 06b, 3C
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-566035
Class A Membership Interests in form of Units
Source: Form D, filed Dec 8, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lawrence Jacobs | Executive |
| Mukesh Prasad | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
C/O Innova Capital Partners 3 Llc 437 Tennyson Drive
Staten Island, NY, 10312
Staten Island, NY, 10312